Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ferroptosis inhibitor D1 is a free radical scavenger and an inhibitor of ferroptosis.1 It scavenges 41.27% of DPPH (Item No. 14805) radicals in a cell-free assay when used at a concentration of 0.4 µM. Ferroptosis inhibitor D1 (0.5 µM) inhibits lipid peroxidation induced by the ferroptosis inducer erastin (Item No. 17754) in HT-1080 cells and inhibits erastin-induced ferroptosis in the same cells (IC50 = 22 nM). In vivo, ferroptosis inhibitor D1 (5 mg/kg) reduces infarct volume and improves neurological deficits in a mouse model of ischemic brain injury induced by transient middle cerebral artery occlusion (MCAO).
WARNING This product is not for human or veterinary use.
1. Discovery of new phenyltetrazolium derivatives as ferroptosis inhibitors for treating ischemic stroke: An example development from free radical scavengers. J. Med. Chem. 67(14), 11712-11731 (2024).